Between Two Benches: Leading a Legacy in Life Sciences
Between Two Benches: Leading a Legacy in Life Sciences
JLABS , 3210 Merryfield Row , San Diego , CA 92121
November 12, 2015 from 12:30 PM to 14:00 PM (PST)
$10 - $35
Ralph Waldo Emerson said that "life is a journey, not a destination" and a successful career in life sciences is no different. Join us to hear about one man's journey that starts with a passion for healthcare in Buenos Aires with stops along the way in academia, medicine, many startups and finally venture capital, where he is currently managing a billion dollar fund with one of the top biotech VC firms in the US. Dr. Pablo Cagnoni earned his medical degree in Argentina, completed fellowships in New York and Colorado, and now resides in California. In addition to a diversity of positions, each region has helped shaped his career by giving him a new perspective on the various and evolving needs of the patient. On November 12th Dr. Cagnoni, now Managing Director at MPM Capital, will share his journey including some major lessons from the road.
The Inspiring Leader Series provides unrivaled access to been there done that industry leaders in an intimate and unique setting. The highly sought after, featured speakers share their forecasts and vision for the future as well as lessons learned from the trenches. The series is designed to be an interactive and inspiring experience for all who attend.
Pablo J. Cagnoni, M.D. | Managing Director, MPM Capital read bio»
[interviewer] Diego Miralles, M.D. | Head, Johnson & Johnson Innovation read bio»
11:30 AM | Registration Opens, Lunch, and Networking
12:00 PM | Presentation, Interview and Q&A
1:00 PM | Program Close
$35 | General Public
$20 | Student/Academic
$45 | At the door
3210 Merryfield Row
San Diego, CA
Pablo J. Cagnoni, M.D. | Managing Director, MPM Capital
Over of the course of his career as an oncologist and pharmaceutical executive, Dr. Cagnoni has been committed to advancing the development of breakthrough treatments for patients with cancer and other debilitating diseases. He has played a key role in the development, approval and/or commercialization of several life-changing medicines, including Afinitor®, Blincyto®, Exjade®, Folotyn® Glivec®, Jakavi®, Kyprolis®, Signifor®, Tarceva®, Tasigna® and Zykadia® among them.
Most recently, he served as President of Onyx Pharmaceuticals where he had global strategic oversight and accountability of the business from early product development to commercialization of the Onyx portfolio. At the time of his departure, Onyx was on track to deliver yearly revenues in excess of $1B and had over 800 employees. Dr. Cagnoni joined Onyx in March 2013, as Executive Vice President, Global Research and Development and Technical Operations, and was named President in October 2013, when Onyx became an Amgen subsidiary. Previously, he was Senior Vice President and Global Head of Clinical Development at Novartis Oncology, where he was responsible for all clinical development, clinical operations, clinical pharmacology and correlative sciences activities for the oncology development pipeline. From 2007 to 2009, Dr. Cagnoni was Senior Vice President and Chief Medical Officer at Allos Therapeutics, and prior to that Chief Medical Officer of OSI Pharmaceuticals. Earlier in his career, he served as Assistant Professor of Medicine, University of Colorado Bone Marrow Transplant Program where he cared for patients undergoing stem cell transplants.
Dr. Cagnoni earned his medical degree from University Buenos Aires School of Medicine, and he completed his fellowship in Hematology and Oncology in Mount Sinai Medical Center, New York and a fellowship in Stem Cell Transplantation at the University of Colorado Health Sciences Center.
Connect with Pablo:
[interviewer] Diego Miralles, M.D. | Head, Johnson & Johnson Innovation
Diego Miralles, M.D., is Head, Johnson & Johnson Innovation, with responsibility for the regional innovation centers located in California, Boston, London and Asia Pacific, as well as JLABS incubators. Diego and his team are focused on accessing the most promising early stage external science and technology and developing collaborations across sectors between external innovators and the Johnson & Johnson Family of Companies. Diego has led a number of key innovation initiatives throughout the global Johnson & Johnson organization. As founding member of Johnson & Johnson Innovation, Diego played a leading role in launching the innovation center in California, and founded the JLABS incubator for life science companies, a model that has been replicated in five locations across North America. Diego established and led Janssen Healthcare Innovation which successfully launched patient-centric Care4Today™ solutions across North America and Europe that have delivered improved outcomes for patients and consumers in areas such as medication adherence, mental health, cardiovascular health and surgical recovery. Diego joined the healthcare industry more than 15 years ago after a dozen years in the hospital and academic worlds, including leading extensive clinical research, primarily focused on HIV/AIDS. Diego has extensive experience in clinical and basic research, including work on antiviral drug development at Tibotec, Trimeris, and Triangle Pharmaceuticals. He currently serves as an adjunct full professor in the Pharmacology Department at the University of California, San Diego (UCSD) and serves on the Board of the Rady Children's Hospital of San Diego and the UCSD Health System. Diego served on the faculty and in clinical practice at Duke University, Durham, NC. He completed his fellowship in Infectious Diseases at Cornell University-New York Hospital following a residency in Internal Medicine at the Mayo Clinic in Rochester, MN. Diego is a graduate of the University of Buenos Aires School of Medicine.
Connect with Diego: